Obesity Surgery

, Volume 19, Issue 7, pp 921–925 | Cite as

Sleeve Gastrectomy Relieves Steatohepatitis in High-Fat-Diet-Induced Obese Rats

  • Yong Wang
  • Jingang LiuEmail author
Research Article



Sleeve gastrectomy is thought to decrease the appetite and body weight of morbid obesity patients in the clinic. The purpose is to investigate the effect of sleeve gastrectomy on preventing steatohepatitis in morbid obesity rats.


Thirty rats were randomized into normal chow group (NC), high-fat-diet group (HD), and sleeve group (SG). Rats in the SG group received sleeve gastrectomy operation. After operation, rats in SG and HD group received a high-fat diet, while rats in the NC group received normal chow. Body weight was measured every 10 days. Thirty days later, animals were sacrificed and blood samples were collected to check total cholesterol, HDL, and triglyceride. Fresh liver sections were made and stained with Nile red and observed under a fluorescence microscope.


Rats in the SG group received a moderate body weight decrease (191 ± 16.2 g) in the first 10 days, while this did not happen in the other two groups (213 ± 13.7 g and 243 ± 11.9 g). At the sacrifice date, weight of rats in the SG group was still much lower than those in the HD group. Plasma triglycerol (102.3 ± 18.6 mg/dL) and cholesterol (84.3 ± 6.1 mg/dL) of rats in the SG group were much lower than those in the HD group (198.5 ± 18.5 mg/dL, 133.9 ± 22.0 mg/dL). Under the fluorescence microscope, adipose infiltration was very obvious in the liver of the HD animals, while adipose infiltration was not serious in the SG group.


High-fat diet can result in obvious body weight increase and hepatic adipose infiltration compared with normal chow. Sleeve gastrectomy can decrease body weight even in high-fat-diet models. Body weight control caused by sleeve gastrectomy can relieve high-fat-diet-induced steatohepatitis in rats.


Bariatric surgery Nile red Sleeve gastrectomy Steatohepatitis Morbid obesity 



The authors thank Dr. Yun Yu for kind help in the design of this trial and Dr. Korryne, Ph.D of Missouri University for the revision of this paper.


  1. 1.
    Guijarro A, Kirchner H, Meguid MM. Catabolic effects of gastric bypass in a diet-induced obese rat model. Curr Opin Clin Nutr Metab Care. 2006;9:423–35.CrossRefGoogle Scholar
  2. 2.
    Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.CrossRefGoogle Scholar
  3. 3.
    Chen CM. Overview of obesity in mainland China. Obes Rev. 2008;9(Suppl 1):14–21.CrossRefGoogle Scholar
  4. 4.
    Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005;11:183–90.CrossRefGoogle Scholar
  5. 5.
    Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta. Science (New York, NY). 2001;293:1673–77.CrossRefGoogle Scholar
  6. 6.
    Guebre-Xabier M, Yang S, Lin HZ, et al. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology (Baltimore, Md). 2000;31:633–40.CrossRefGoogle Scholar
  7. 7.
    Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology (Baltimore, Md). 2005;42:880–5.CrossRefGoogle Scholar
  8. 8.
    Elinav E, Pappo O, Sklair-Levy M, et al. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol. 2006;209:121–8.CrossRefGoogle Scholar
  9. 9.
    Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549–57.CrossRefGoogle Scholar
  10. 10.
    Kelley DE. Thermodynamics, liposuction, and metabolism. N Engl J Med. 2004;350:2542–44.CrossRefGoogle Scholar
  11. 11.
    Kirchner H, Guijarro A, Meguid MM. Is a model useful in exploring the catabolic mechanisms of weight loss after gastric bypass in humans? Curr Opin Clin Nutr Metab Care. 2007;10:463–74.CrossRefGoogle Scholar
  12. 12.
    Hill JO, Wyatt HR, Reed GW, et al. Obesity and the environment: where do we go from here? Science (New York, NY). 2003;299:853–5.CrossRefGoogle Scholar
  13. 13.
    Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350:1075–79.CrossRefGoogle Scholar
  14. 14.
    Pinkney JH, Sjostrom CD, Gale EA. Should surgeons treat diabetes in severely obese people? Lancet. 2001;357:1357–59.CrossRefGoogle Scholar
  15. 15.
    Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.CrossRefGoogle Scholar
  16. 16.
    Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.CrossRefGoogle Scholar
  17. 17.
    Deitel M, Crosby RD, Gagner M. The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25–27, 2007. Obes Surg. 2008.Google Scholar
  18. 18.
    Greenspan P, Mayer EP, Fowler SD. Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol. 1985;100:965–73.CrossRefGoogle Scholar
  19. 19.
    Garcia VF, DeMaria EJ. Adolescent bariatric surgery: treatment delayed, treatment denied, a crisis invited. Obes Surg. 2006;16:1–4.CrossRefGoogle Scholar
  20. 20.
    Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (2005). 2007;31:1–14.CrossRefGoogle Scholar
  21. 21.
    Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:3–20.PubMedGoogle Scholar
  22. 22.
    Liew PL, Lee WJ, Wang W, et al. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity. Obes Surg. 2008; 18:847–53.CrossRefGoogle Scholar
  23. 23.
    Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (Baltimore, Md). 2003;37:1202–19.CrossRefGoogle Scholar
  24. 24.
    Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. Jama. 2002;288:1723–27.CrossRefGoogle Scholar
  25. 25.
    Dixon JB, Pories WJ, O’Brien PE, et al. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care. 2005;28:472–4.CrossRefGoogle Scholar
  26. 26.
    Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–29.CrossRefGoogle Scholar
  27. 27.
    Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg. 2006;16:554–9.CrossRefGoogle Scholar
  28. 28.
    Cohen R, Uzzan B, Bihan H, et al. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg. 2005;15:1501–502.CrossRefGoogle Scholar
  29. 29.
    Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–1456CrossRefGoogle Scholar
  30. 30.
    Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.CrossRefGoogle Scholar
  31. 31.
    Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–26.CrossRefGoogle Scholar
  32. 32.
    Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–407.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  1. 1.Hepatobiliary Department, Shengjing HospitalChina Medical UniversityShenyangChina

Personalised recommendations